Email Updates

Search form

You are here

Early HIV vaccine study raises hopes for ongoing larger trial

Include in
Media Coverage

Findings from an early Phase I/IIa primate and human trial of the so-called mosaic HIV vaccine showed encouraging signs of the vaccine’s ability to prompt an immune response to the virus and backed the ongoing human efficacy trial of the vaccine currently running in sub-Saharan Africa, MedPage Today reports.

July 10, 2018
POZ